U.S. flag

An official website of the United States government

NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys) AND not provided

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Jan 1, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000212892.17

Allele description [Variation Report for NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)]

NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)

Gene:
PTPN11:protein tyrosine phosphatase non-receptor type 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.13
Genomic location:
Preferred name:
NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)
Other names:
p.E76K:GAG>AAG
HGVS:
  • NC_000012.12:g.112450406G>A
  • NG_007459.1:g.36675G>A
  • NM_001330437.2:c.226G>A
  • NM_001374625.1:c.223G>A
  • NM_002834.4:c.226G>A
  • NM_002834.5:c.226G>AMANE SELECT
  • NM_080601.3:c.226G>A
  • NP_001317366.1:p.Glu76Lys
  • NP_001317366.1:p.Glu76Lys
  • NP_001361554.1:p.Glu75Lys
  • NP_002825.3:p.Glu76Lys
  • NP_542168.1:p.Glu76Lys
  • LRG_614t1:c.226G>A
  • LRG_614:g.36675G>A
  • NC_000012.11:g.112888210G>A
  • NM_001330437.1:c.226G>A
  • NM_002834.3:c.226G>A
  • Q06124:p.Glu76Lys
Protein change:
E75K; GLU76LYS
Links:
UniProtKB: Q06124#VAR_016000; OMIM: 176876.0014; dbSNP: rs121918464
NCBI 1000 Genomes Browser:
rs121918464
Molecular consequence:
  • NM_001330437.2:c.226G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374625.1:c.223G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002834.5:c.226G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080601.3:c.226G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000057381GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Jun 3, 2021)
germlineclinical testing

Citation Link,

SCV000927623Blueprint Genetics
criteria provided, single submitter

(Blueprint Genetics Variant Classification Scheme)
Pathogenic
(Apr 9, 2018)
germlineclinical testing

Citation Link,

SCV003917245CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(Jan 1, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000057381.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Reported in published literature in patients with juvenile myelomonocytic leukemia (Kratz et al., 2005); Reported in published literature in association with somatic hematologic malignancies (Tartaglia et al., 2006); Published functional studies demonstrate a damaging effect on protein function and structure (Tartaglia et al., 2006; Gagne-Sansfaon et al., 2016); The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 22391158, 17177198, 29206716, 27582544, 15928039, 16358218, 9491886, 16053901, 11992261, 29493581, 27535533, 27783593, 23825065, 31222725, 15842656, 15385933, 14982869, 32697817, 12717436, 21930766, 19047918, 18470943, 14644997)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Blueprint Genetics, SCV000927623.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV003917245.13

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

PTPN11: PM1, PM2, PM5, PP2, PP3, PS3:Supporting, PS4:Supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 3, 2024